Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122912164 | 12291216 | 4 | F | 20160409 | 20160917 | 20160421 | 20160926 | EXP | US-BIOGEN-2016BI00223831 | BIOGEN | 54.72 | YR | F | Y | 93.52000 | KG | 20160926 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122912164 | 12291216 | 1 | PS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | P41081 | 103628 | 30 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | |||||||
| 122912164 | 12291216 | 2 | SS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | P41081 | 103628 | UNKNOWN | /wk | ||||||||
| 122912164 | 12291216 | 3 | SS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | P41081 | 103628 | UNKNOWN | /wk | ||||||||
| 122912164 | 12291216 | 4 | SS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | P41081 | 103628 | SOLN FOR INJECT IN PRE-FILLED SYRINGE | /wk | ||||||||
| 122912164 | 12291216 | 5 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 122912164 | 12291216 | 6 | C | PACLITAXEL. | PACLITAXEL | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122912164 | 12291216 | 1 | Relapsing-remitting multiple sclerosis |
| 122912164 | 12291216 | 5 | Neoplasm malignant |
| 122912164 | 12291216 | 6 | Neoplasm malignant |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122912164 | 12291216 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122912164 | 12291216 | Cardiac failure | |
| 122912164 | 12291216 | Disorientation | |
| 122912164 | 12291216 | Dysstasia | |
| 122912164 | 12291216 | Fatigue | |
| 122912164 | 12291216 | Hyperhidrosis | |
| 122912164 | 12291216 | Muscular weakness | |
| 122912164 | 12291216 | Pyrexia | |
| 122912164 | 12291216 | Rash macular |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122912164 | 12291216 | 1 | 201505 | 0 | ||
| 122912164 | 12291216 | 2 | 20080326 | 20101011 | 0 | |
| 122912164 | 12291216 | 3 | 20040620 | 20070120 | 0 | |
| 122912164 | 12291216 | 4 | 20150530 | 0 |